Active, Not Recruiting
Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)
NCT04385277
- Conditions
- Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neoplasms, +9 more
- Locations
-
- Banner Children's at Desert Mesa, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center Downey, California, United States
- Children's Hospital Los Angeles Los Angeles, California, United States